Key Market Indicators
Sales of analgesic medicine in Sweden are set to reach $250 million by 2026. According to data from 2021, the market was worth $253.66 million, growing at a rate of 0.2% year-on-year since 2005. In 2021, Sweden was ranked 8th worldwide in terms of analgesic medicine sales. Belgium took the lead with $253.66 million, followed by Spain, Canada and Italy in second, third and fourth place respectively.
